Business · 08/05/2001Updated: 10/17/2026 · 1 min read
FDA Announces OMB Approval for MedWatch Program Under Paperwork Reduction Act of 1995
Summary
The Food and Drug Administration (FDA) has announced that its MedWatch program, a medical products reporting system, has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995. This approval allows the FDA to collect information from the public through the MedWatch program.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →